Navigation Links
The Female Health Company Reports Record First Quarter FY2013 Operating Results
Date:1/30/2013

assets

$
30,485,968$
30,446,427Accounts payable

$
,499,399$
,775,327Accrued expenses and other current liabilities

1,771,0591,095,732Accrued compensation

644,9912,964,812Accrued dividends

1,733,68024,570Total current liabilities

5,649,1295,860,441Deferred rent

84,91190,902Deferred grant income

76,44282,650Deferred income taxes

192,821194,244Total liabilities

6,003,3036,228,237Total stockholders' equity

24,482,66524,218,190Total liabilities and stockholders' equity

$
30,485,968$
30,446,427The Female Health CompanyUnaudited Condensed Consolidated Income StatementsThree Months Ended
December,20122011Net revenues

$
9,910,227$
8,634,442Cost of sales

3,944,0283,618,298Gross profit

5,966,1995,016,144Operating expenses

2,365,1652,232,864Operating income

3,601,0342,783,280Interest and other (expense) income

(4,244)355Foreign currency transaction loss

(37,267)(52,306)Income before income taxes

3,559,5232,731,329Income tax expense

25,67771,385Net income

$
3,533,846$
2,659,944Net income per basic common share outstanding

$ 0.12$ 0.10Basic weighted average common shares outstanding

28,333,36027,480,011Net income per diluted common share outstanding

$ 0.12$ 0.09Diluted weighted average common shares outstanding

28,694,90328,883,710Cash dividends declared per common share

$0.12$0.10
'/>"/>

SOURCE The Female Health Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The Female Health Company To Report First Quarter Operating Results on Wednesday, January 30, 2013
2. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
3. The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 2012
4. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
5. Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Companys Inaccurate Description of Federal Courts Recent Certification Ruling
6. The Female Health Company Reports Second Quarter Operating Results
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. Genomic Health to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, February 6, 2013
9. Natural Tree Extract (Larch Arabinogalactan) Shown to Have Statistically Significant Effect in Protecting Immune Health
10. RedBrick Healths New Approach to Health Engagement and Behavior Change Propels Record Growth in its Employee Health and Wellness Business
11. Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Wash. , July 28, 2015 A ... of Nutraceutix,s L. reuteri probiotic enriches human ... that increase insulin secretion.  The study involved daily administration ... SD-5865) in tablets using the patented BIO- tract ... damage by stomach acid on their way to the ...
(Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
(Date:7/28/2015)... The Physician-Patient Alliance for Health & Safety ... Surviving Your Hospital Stay ." "Help us ... of these patients went home from hospital," said ... referring to the patient stories presented at ... Promote Continuous Monitoring of Patients on Opioids (shown ...
Breaking Medicine Technology:Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2
... Feb. 25 Dr. Robert B. Arnot ... The Silent Threat," the result of months of comprehensive ... hard surfaces are emerging as a key source of bacterial ... correspondent and Chief Medical Educator of www.touchsurfaces.org , also ...
... March 11 Caraco Pharmaceutical Laboratories, Ltd. (NYSE: ... 50mg and 100mg oxaliplatin injections, which are therapeutically equivalent ... Food and Drug Administration (FDA) for Sun Pharma,s Abbreviated ... in the treatment of colon and rectal cancer. Oxaliplatin ...
Cached Medicine Technology:Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases 2Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3
(Date:7/29/2015)... ... ... are privileged to announce that U.S. News & World Report has ranked the ... the nation for 2015-2016. This marks the 21st consecutive year that the USC Eye Institute ... honor to be included in the top 10 ophthalmology hospitals by U.S. News & World ...
(Date:7/29/2015)... , ... July 29, 2015 , ... July is National UV Awareness Month, and in ... DC shares tips on how to protect skin from the sun, as well as how ... cancer, and is one of the most common skin conditions in America. Many people do ...
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for ... is a tremendous model of care. One that is very hands on and resident ... director of Monarch Landing. “She’s bringing great passion and energy, as well as a ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Several years ... population of children with autism, Little City took a proactive stance and began planning ... The Coleman Foundation grant provides valuable support to building the third home. , “We ...
(Date:7/29/2015)... ... July 29, 2015 , ... Zofran lawsuits ... Panel on Multidistrict Litigation (JPML), according to court documents.* Attorneys handling Zofran ... the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate and ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4
... The University of Liverpool has launched an i-phone ... patients with instant and easy access to information ... website ( www.hiv-druginteractions.org ), HIV iChart is a ... with immediate access to information on potential drug ...
... food labels, and will eat more of something if they ... in the Journal of Consumer Research . Authors ... of Michigan) found that inconsistent portion sizes contribute to people,s ... of large portion sizes and consumer uncertainty about appropriate food ...
... HealthDay Reporter , MONDAY, Nov. 15 (HealthDay News) ... alternative to warfarin (Coumadin), the standard for decades to ... as atrial fibrillation. In research presented Monday at ... reported that rivaroxaban (Xarelto) proved to be just as ...
... and health in adolescents, conducted by researchers at Yale ... to gaming as well as important health risks associated ... Pediatrics , the study is among the first and ... problematic gaming in a community sample of adolescents. ...
... hormone-based therapy for prostate cancer faced a 30 percent to ... who did not receive this treatment, according to a new ... therapy, a common type of treatment for prostate cancer that ... of the testicles or a series of injections. It,s been ...
... HealthDay Reporter , MONDAY, Nov. 15 (HealthDay News) -- ... attack death rates in public places such as restaurants, malls ... increase the risk of death when used in hospitals, a ... with the type of heart rhythms associated with the heart ...
Cached Medicine News:Health News:University launches iPhone app to access HIV drug expertise 2Health News:Guiltless gluttony: Misleading size labels lead to overeating 2Health News:New Blood Thinner a Promising Alternative to Warfarin 2Health News:New Blood Thinner a Promising Alternative to Warfarin 3Health News:When video games get problematic so do smoking, drug use and aggression 2Health News:Prostate cancer treatment linked to higher rate of colon cancer, study finds 2Health News:External Defibrillators Not Much Help in Hospitals 2Health News:External Defibrillators Not Much Help in Hospitals 3
... The DTX Series Multimode Detectors ... a variety of application and automation ... and absorbance measurements on the same ... as standalone instruments or can be ...
... Series Multimode Detectors provide unmatched value ... application and automation needs. Capable of ... on the same instrument, the DTX ... or can be integrated seamlessly with ...
GENios Pro, TECANs advanced, multi-functional injector reader offers simultaneous reagent dispensing and detection for monitoring of fast kinetic reactions...
... and quantitate contaminants, such as residual host ... (e.g., BSA, IgG, insulin, transferrin), Proteins A ... can be bound by antibodies as well ... The system reduces the time required to ...
Medicine Products: